Stockscreener 앱 받기
0.4107
5.17%
-0.0224
시장 영업 전:
.43
0.0193
+4.70%
Fractyl Health Inc 주식(GUTS)의 최신 뉴스
Insider Sell: What is the dividend yield of Fractyl Health IncJuly 2025 Final Week & AI Driven Price Predictions - baoquankhu1.vn
Risk Off: How correlated is Fractyl Health Inc to the S P500Quarterly Trade Report & Community Consensus Trade Signals - baoquankhu1.vn
Aug Technicals: Does Fractyl Health Inc have pricing powerJuly 2025 EndofMonth & Long Hold Capital Preservation Plans - baoquankhu1.vn
Fractyl Health, Inc. (NASDAQ:GUTS) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Even endpoint hits don’t spare shares in three weight-loss updates - BioCentury
Why Fractyl Health Inc. stock remains a top recommendationJuly 2025 Recap & Expert Approved Trade Ideas - mfd.ru
Market Trends: Is Fractyl Health Inc benefiting from interest rate changesJuly 2025 Sector Moves & Free Reliable Trade Execution Plans - baoquankhu1.vn
Fractyl Health: Unreasonably Low Market Expectations Create A Trading Opportunity Towards 2026 Catalysts - Seeking Alpha
Fractyl Health plummets on data for Revita for weight loss maintenance - MSN
Why did GUTS stock plummet today despite positive gut therapy midterm study? - MSN
Fractyl Health (GUTS) Is Down 78.0% After Positive REMAIN-1 Midpoint Data And De Novo FDA PlanHas The Bull Case Changed? - Sahm
Fractyl Health Shares Fall After Morgan Stanley Downgrade - marketscreener.com
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Fractyl Health, Inc. Investigated on Behalf of InvestorsContact the DJS Law Group to Discuss Your Rights – GUTS - marketscreener.com
Institutional Owners May Take Dramatic Actions as Fractyl Health, Inc.'s (NASDAQ:GUTS) Recent 72% Drop Adds to One-year Losses - 富途牛牛
Fractyl Health (GUTS) Tests Whether Revita Can Redefine Post-GLP-1 Weight Maintenance Economics - Yahoo Finance
Revita treatment shows promise for weight maintenance after GLP-1 use By Investing.com - Investing.com South Africa
Morgan Stanley downgrades Fractyl Health stock rating to Equalweight on Revita trial results By Investing.com - Investing.com South Africa
Morgan Stanley downgrades Fractyl Health stock rating to Equalweight on Revita trial results - Investing.com India
What if Oprah Knew About Fractyl Health? - MedCity News
Why Is Fractyl Health Stock Tumbling Today?Fractyl Health (NASDAQ:GUTS) - Benzinga
Fractyl Health's Revita reduces post-GLP-1 weight regain by ~70% - TechTarget
Crude Oil Surges 3%; Caterpillar Shares Gain After Q4 Results - Benzinga
Fractyl Health announces compelling 6-month randomized Remain-1 midpoint data showing durable weight maintenance with Revita after GLP-1 discontinuation - marketscreener.com
Fractyl Health Showcases 6-Month REMAIN-1 Data as Revita Curbs Post-GLP-1 Weight Regain - MarketBeat
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Fractyl’s Revita reduces post-GLP-1 weight regain 70% - BioWorld MedTech
GUTS: Revita cut post-GLP-1 weight regain by 70% in high-risk patients at six months, with strong safety - TradingView
US Stocks Mixed; Tesla Posts Upbeat Q4 Earnings - Benzinga
Why Did GUTS Stock Plummet Today Despite Positive Gut Therapy Midterm Study? - Stocktwits
GUTS: Revita shows robust six-month weight maintenance post-GLP-1, supporting pivotal study success - TradingView
Fractyl Health Advances Revita for Post-GLP-1 Weight Maintenance - TipRanks
Will Fractyl Health Inc. outperform during market ralliesQuarterly Profit Summary & Safe Entry Momentum Stock Tips - mfd.ru
Fractyl Health's Revita Demonstrates Durable Weight Maintenance; Shares Fall Despite Positive Data - Nasdaq
Revita treatment shows promise for weight maintenance after GLP-1 use - Investing.com Canada
Fractyl Health Announces 6-Month REMAIN-1 Midpoint Data - TradingView
Revita trial cuts post-GLP-1 weight regain at Fractyl Health (GUTS) - stocktitan.net
Fractyl Health stock falls after midpoint data on GLP-1 weight maintenance By Investing.com - Investing.com South Africa
Fractyl Health stock falls after midpoint data on GLP-1 weight maintenance - Investing.com Canada
Fractyl Health Announces Compelling 6-Month Randomized Remain-1 Midpoint Data Showing Durable Weight Maintenance With Revita® After Glp-1 Discontinuation - TradingView
Fractyl Health Announces Compelling 6-Month Randomized REMAIN-1 Midpoint Data Showing Durable Weight Maintenance with Revita® After GLP-1 Discontinuation - The Manila Times
GUTS: Revita shows sustained weight maintenance and safety post-GLP-1, with key 2026 milestones ahead - TradingView
Fractyl Health Announces Compelling 6-Month Randomized - GlobeNewswire
Biotech Alert: Searches spiking for these stocks today - TipRanks
HC Wainwright Forecasts Fractyl Health FY2030 Earnings - MarketBeat
U.S. Bio Firms Develop Single-Injection Gene Therapies to Cure Obesity - 조선일보
The next frontier in weight-loss drugs: one-time gene therapy - The Washington Post
Volume Summary: Is Fractyl Health Inc undervalued by DCF analysis2025 Technical Patterns & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Short Interest in Fractyl Health, Inc. (NASDAQ:GUTS) Expands By 24.0% - MarketBeat
What is the PEG ratio of Fractyl Health Inc.Quarterly Trade Review & Consistent Return Investment Signals - bollywoodhelpline.com
Earnings Risk: What is the dividend yield of Fractyl Health IncTrade Signal Summary & Community Supported Trade Ideas - baoquankhu1.vn
Is Fractyl Health Inc undervalued by DCF analysis2025 Pullback Review & High Accuracy Swing Trade Signals - baoquankhu1.vn
MACD Signal: What is the earnings history of Fractyl Health IncJobs Report & Safe Entry Zone Identification - baoquankhu1.vn
Returns Recap: Is BNAI still a buy after recent gainsWeekly Trend Recap & Capital Efficient Trading Techniques - baoquankhu1.vn
Investment Review: Is Fractyl Health Inc in a long term uptrendJuly 2025 Outlook & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
1.24%
0.19%
자본화:
|
볼륨(24시간):